- videocam On-Demand Webinar
- signal_cellular_alt Intermediate
- card_travel Health
- schedule 90 minutes
Healthcare Noncompete and No-Poach Agreements: Navigating Evolving Federal Regulations and Rapidly Changing State Laws
Potential Impact of Loper Bright and the New Administration
Welcome! Strafford is now BARBRI! The expert courses you know from the trusted global leader in legal education.
About the Course
Introduction
This CLE course will guide healthcare counsel on noncompete agreements and other restrictive covenants in healthcare. The panel will provide an update on current federal regulation and evolving state laws for the use of noncompete and no-poach agreements in the healthcare industry taking into account the recent Loper Bright decision and new presidential administration. The panel will also examine the state of the DOJ's no-poach prosecutions and the potential for private litigation. The panel will offer best practices for navigating noncompete and no-poach agreements in healthcare in a rapidly evolving regulatory environment.
Description
Many life sciences companies and other healthcare providers have encountered noncompete, no-poach, and other restrictive covenant agreements. These agreements are often a condition of employment or are used to prevent unfair competition and protect employers' trade secrets and customer relationships.
In recent years under the Biden administration, the FTC and NLRB have taken strong stances limiting the use of noncompete and no-poach agreements. And the DOJ has pursued no-poach prosecutions. However, this may all be impacted by the Loper Bright decision and the incoming presidential administration.
In addition to federal regulation, the healthcare industry must also consider state laws regulating the use of restrictive covenants. In recent years, an increasing number of states have introduced and/or enacted legislation related to noncompetes, many of them focused on the healthcare industry in one way or another.
Listen as our authoritative panel discusses the current status of federal regulation of noncompete and no-poach agreements and possible state law interaction. The panel will also examine how this area may evolve and offer best practices for navigating noncompete and no-poach agreements in healthcare.
-
This 90-minute webinar is eligible in most states for 1.5 CLE credits.
-
Live Online
On Demand
Date + Time
- event
Wednesday, January 15, 2025
- schedule
1:00 p.m. ET./10:00 a.m. PT
- Restrictive covenants in healthcare: federal regulatory update
- FTC
- NLRB
- DOJ no-poach prosecutions
- Private litigation
- Possible impact of Loper Bright and a new administration
- Notable state laws
- Best practices for noncompete and no-poach agreements in healthcare
The panel will review these and other issues:
- What is the current state of federal noncompete regulation? How may this be impacted by the Loper Bright decision and a new administration?
- How are state laws changing generally and as they apply in the healthcare industry?
- What is the status of the DOJ's criminal no-poach prosecutions?
- How can the healthcare industry properly implement restrictive covenants while complying with rapidly changing state and federal laws and administrative guidance?
Unlimited access to premium CLE courses:
- Annual access
- Available live and on-demand
- Best for attorneys and legal professionals
Unlimited access to premium CPE courses.:
- Annual access
- Available live and on-demand
- Best for CPAs and tax professionals
Unlimited access to premium CLE, CPE, Professional Skills and Practice-Ready courses.:
- Annual access
- Available live and on-demand
- Best for legal, accounting, and tax professionals
Unlimited access to Professional Skills and Practice-Ready courses:
- Annual access
- Available on-demand
- Best for new attorneys
Related Courses
#MeToo and Medical Staffs: Handling Allegations of Physician Sexual Misconduct
Available On-Demand
CMS Nationwide Moratoria on New Hospice and Home Health Medicare Enrollments: Covered Entities, Industry Impact
Wednesday, July 8, 2026
1:00 PM ET/10:00 AM PT
Clinical Trials and Human Research: Complying With Regulatory Obligations; Privacy Considerations
Tuesday, August 4, 2026
1:00 p.m. ET./10:00 a.m. PT
100% Tariffs Impacting the Pharmaceutical Industry: Section 232, Complex Multi-Tiered Rate Structure, Exemptions
Thursday, July 16, 2026
1:00 PM ET/10:00 AM PT
Recommended Resources